CAS: 514-65-8; 1-(Bicyclo[2.2.1]Hept-5-En-2-yl)-1-Phenyl-3-(Piperidin-1-yl)Propan-1-Ol

该化合物是一种抗胆碱药物,主要用于治疗帕金森病和药物引起的毒死性外症状,它的作用是阻塞肌肉受体的乙酰胆碱酯酶作用,这有助于恢复脑部多巴胺和乙酰胆碱之间的平衡,缓解颤动和僵硬等症状.Biperiden通常通过口服,以其跨越血液脑屏障的能力为名,这对治疗效果至关重要.该物质的特点是化学配方,包括管状,有助于其药理活动.常见副作用可能包括干嘴,视力模糊,精密和尿液保留,反映其抗胆碱性.Biperiden被归类为抗巴金胺剂类别,并经常与其他药物一起处方,以提高治疗结果.与任何药物一样,重要的是在医疗监督下使用双环,以有效地管理可能的相互作用和副作用.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    1-(双环[2.2.1]庚-5-烯-2-基)-3-(1-哌啶基)-1-丙酮,Phenyl Magnesium 反应生成 比哌立登
    参考文献:Method For The Production Of Biperidin
    标题:Method For The Production Of Biperidin
    摘要:本发明涉及一种生产双氢异奎尼的方法,该方法是通过将1-(双环[2.2.1]庚-5-烯-2-基)-3-哌啶基-1-丙酮的外/内混合物与苯基镁化合物反应,形成1-(双环[2.2.1]庚-5-烯-2-基)-1-苯基-3-哌啶基-1-丙醇的异构体混合物,从而通过将该混合物转化为相应的盐酸盐,分离所述盐酸盐,再转化为游离基,并结晶化所述双氢异奎尼而获得.

    海关参考信息

    专利信息


    专利号:WO-2008065672-A3
    优先权日:2006-11-27
    标题 :A process for producing acetylnorbornene, an intermediate in the synthesis of biperiden
    发明人:GOTTUMUKKALA VENKATA SUBBARAJU; MAMILLAPALLI RAMBHADRA SARMA; TERLI CHIRANJEEVI
    权利人:SAIRAM ORGANICS PVT LTD; GOTTUMUKKALA VENKATA SUBBARAJU; MAMILLAPALLI RAMBHADRA SARMA; TERLI CHIRANJEEVI
    摘要:The present invention relates to a novel process for the production of acetylnorbornene, efficiently and industrially useful manner. The process is applicable for the large scale production of acetylnorbornene and consists of preparation of 5-cyanonorbornene and its reaction with appropriate Grignard reagents. The product contains higher proportion of the exo form than the endo form, which is important for the synthesis of biperiden.

    专利号:WO-2025128098-A1
    优先权日:2023-12-13
    标 题 :Solid oral dosage forms, kits, and methods of using the same
    发明人:LI YING; LANGER ROBERT; TRAVERSO CARLO
    权利人:MASSACHUSETTS INST TECHNOLOGY; BRIGHAM & WOMENS HOSPITAL INC
    摘要:Provided herein are solid oral dosage forms, methods, and kits useful, e.g, for the extension of the residence time of active pharmaceutical agents in vivo by the synthesis of a polymer in situ in a subject. In particular, the solid oral dosage forms, methods, and kits disclosed herein are particularly useful for drugs that require more than once daily administration (e.g, drugs that have short half-lives).

    专利号:US-2009285888-A1
    优先权日:2005-05-13
    标题:Derivatives of dihydroxyphenylalanine
    发明人:SUSILO GISELA
    权利人:SUSILO GISELA
    摘要:The invention relates to derivatives of dihydroxyphenylalanine, to their synthesis and to pharmaceutical compositions containing said derivatives of dihydroxyphenylalanine. Furthermore, the invention relates to the use of said derivatives of dihydroxyphenylalanine and said pharmaceutical compositions for the treatment and prophylaxis of movement disorders, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, hemiparkinson-hemiatrophy, parkinsonian syndrome, Lewy body disease, frontotemporal dementia, Lytico-Bodig disease (parkinsonism/dementia/amyotrophic lateral sclerosis), striatonigral degeneration, Shy-Drager syndrome, sporadic olivopontocerebellar degeneration, progressive atrophy of the globus pallidus, progressive supranuclear palsy, Hallervorden-Spatz disease, Huntington's disease, X-linked dystonia-parkinsonism (Lubag), mitochondrial cytopathy with striatal necrosis, neuroacanthocytosis, restless legs syndrome, Wilson's disease.

    专利号:US-8697888-B2
    优先权日:2012-01-06
    标题 :Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine M1 receptors
    发明人:LINDSLEY CRAIG W; CONN P JEFFREY; WOOD MICHAEL R; MELANCON BRUCE J; CHEUNG YIU-YIN
    权利人:UNIV VANDERBILT
    摘要:In one aspect, the invention relates to substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs, derivatives thereof, and related compounds, which are useful as antagonists of the muscarinic acetylcholine receptor M 1 (mAChR M 1 ); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

    专利号:US-9056875-B2
    优先权日:2012-08-31
    标 题 :Substituted pyrazolo[3′,4′:4,5]thieno[2,3-C]pyridazin-3-amine analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4
    发明人:LINDSLEY CRAIG W; CONN P JEFFREY; WOOD MICHAEL R; SALOVICH JAMES M
    权利人:UNIV VANDERBILT
    摘要:In one aspect, the invention relates to substituted pyrazolo[3′,4′:4,5]thieno[2,3-c]pyridazine-3-amine analogs, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M 4 (mAChR M 4 ); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

    专利号:US-9073935-B2
    优先权日:2011-11-11
    标 题:Substituted benzylspiroindolin-2-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M1
    发明人:LINDSLEY CRAIG W; CONN P JEFFREY; WOOD MICHAEL R; HOPKINS COREY R; MELANCON BRUCE J; POSLUSNEY MICHAEL S
    权利人:UNIV VANDERBILT
    摘要:In one aspect, the invention relates to substituted benzylspiroindolin-2-one analogs compounds, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M 1 (mAChR M 1 ); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    常州市金坛区水北医药化工厂
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sb-pharm.com
    电话: 086-519-2551234👤
    📞常州市金坛区水北医药化工厂 ⚠️参考联系方式

    销售电话:086-519-2551234
    邮箱:sales@sb-pharm.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Sambeth A, Riedel WJ, Klinkenberg I, Kähkönen S, Blokland A. Biperiden selectively induces memory impairment in healthy volunteers: no interaction with citalopram. Psychopharmacology (Berl). 2015 Jun;232(11):1887-97. doi: 10.1007/s00213-014-3822-9. Epub 2014 Dec 4. doi: 10.1016/j.euroneuro.2014.06.001. Epub 2014 Jun 12. Russian. doi: 10.1016/j.bbr.2014.08.036. Epub 2014 Aug 24. doi: 10.1097/JCP.0000000000000421. doi: 10.4155/bio.12.292. doi: 10.1016/j.etap.2012.04.004. Epub 2012 Apr 10. doi: 10.1016/j.yebeh.2012.09.009. Epub 2012 Nov 13. doi: 10.1186/1744-9081-9-4.
    10: Ramos AC, Andersen ML, Oliveira MG, Soeiro AC, Galduróz JC. Biperiden (M₁ antagonist) impairs the expression of cocaine conditioned place preference but potentiates the expression of cocaine-induced behavioral sensitization. Behav Brain Res. 2012 May 16;231(1):213-6. doi: 10.1016/j.bbr.2012.03.030. Epub 2012 Mar 26. doi: 10.1016/j.pnpbp.2010.08.030. Epub 2010 Sep 7. doi: 10.1016/j.bbr.2011.07.050. Epub 2011 Aug 10. doi: 10.1016/j.neulet.2012.01.073. Epub 2012 Feb 7. doi: 10.1016/j.schres.2010.02.1060. Epub 2010 Mar 17. doi: 10.1017/S1461145711001647. Epub 2011 Nov 18.
    17: Takahashi S, Suzuki M, Uchiyama M. A case of schizophrenia with meige syndrome induced by perospirone successfully treated with biperiden. J Neuropsychiatry Clin Neurosci. 2013 Winter;25(1):E28. doi: 10.1176/appi.neuropsych.12020029. doi: 10.1007/s00213-011-2171-1. Epub 2011 Feb 19.

    合成参考文献


    参考文献:10.1007/s10549-011-1595-y
    摘要:Creighton CJ, Sada YH, Zhang Y, Tsimelzon A, Wong H, Dave B, Landis MD, Bear HD, Rodriguez A, Chang JC. A gene transcription signature of obesity in breast cancer. Breast Cancer Research and Treatment. 2011 Jul 13;132(3):993–1000. doi: 10.1007/s10549-011-1595-y.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知